OpenAI-Backed Red Queen Bio Designs Antibodies with AI
5 Articles
5 Articles
OpenAI-backed Red Queen Bio designs antibodies with AI
Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million in total to design antibody drugs against viruses, including ones that AI systems could one day help create, The Wall Street Journal reported. The company is starting with antibodies against bird flu and other influenza viruses and plans its first clinical trials […] This story continues at The Next Web
Bioengineers in the United States have begun to prepare for future AI pandemics with the help of neural networks, the WSJ writes
Bioengineers in the United States have begun to prepare for future AI pandemics with the help of neural networks, the WSJ writes.They want to prepare in advance and invent antibody drugs against viruses that criminals can potentially create with the...
Red Queen Bio uses I.I. to develop antibodies against potential pathogens, in particular influenza viruses and future biological threats.
OpenAI-backed startup uses models to design biological defenses faster than the capabilities of systems that could be used to create threats grow.There's an awkward starting point in Red Queen Bio's business and the company doesn't hide it: its mission is to scale biological defenses more... Continue reading »The news Red Queen Bio designs AI antibodies to curb the pandemic AI itself was originally published on Wwwhatsnew.com by Natalia Polo.
Red Queen Bio is already using artificial intelligence to design antibodies against pathogens that could arise from future biological threats.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
